Savvidis, C.; Kouroglou, E.; Kallistrou, E.; Ragia, D.; Dionysopoulou, S.; Gavriiloglou, G.; Tsiama, V.; Proikaki, S.; Belis, K.; Ilias, I.
IGFBP-2 in Critical Illness: A Prognostic Marker in the Growth Hormone/Insulin-like Growth Factor Axis. Pathophysiology 2024, 31, 621-630.
https://doi.org/10.3390/pathophysiology31040045
AMA Style
Savvidis C, Kouroglou E, Kallistrou E, Ragia D, Dionysopoulou S, Gavriiloglou G, Tsiama V, Proikaki S, Belis K, Ilias I.
IGFBP-2 in Critical Illness: A Prognostic Marker in the Growth Hormone/Insulin-like Growth Factor Axis. Pathophysiology. 2024; 31(4):621-630.
https://doi.org/10.3390/pathophysiology31040045
Chicago/Turabian Style
Savvidis, Christos, Eleni Kouroglou, Efthymia Kallistrou, Dimitra Ragia, Sofia Dionysopoulou, Georgios Gavriiloglou, Vasiliki Tsiama, Stella Proikaki, Konstantinos Belis, and Ioannis Ilias.
2024. "IGFBP-2 in Critical Illness: A Prognostic Marker in the Growth Hormone/Insulin-like Growth Factor Axis" Pathophysiology 31, no. 4: 621-630.
https://doi.org/10.3390/pathophysiology31040045
APA Style
Savvidis, C., Kouroglou, E., Kallistrou, E., Ragia, D., Dionysopoulou, S., Gavriiloglou, G., Tsiama, V., Proikaki, S., Belis, K., & Ilias, I.
(2024). IGFBP-2 in Critical Illness: A Prognostic Marker in the Growth Hormone/Insulin-like Growth Factor Axis. Pathophysiology, 31(4), 621-630.
https://doi.org/10.3390/pathophysiology31040045
